Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LABS.L Stock Summary
Top 10 Correlated ETFs
LABS.L
In the News
LABS.L Financial details
Company Rating
Buy
Market Cap
152.6M
Income
-
Revenue
-
Book val./share
0.9
Cash/share
0.06
Dividend
0.03
Dividend %
0.05%
Employees
-
Optionable
No
Shortable
Yes
Earnings
19 Sep 2024
P/E
-8.06
Forward P/E
-
PEG
-
P/S
-11.17
P/B
0.7
P/C
655
P/FCF
-204.6
Quick Ratio
20.42
Current Ratio
20.42
Debt / Equity
0.31
LT Debt / Equity
0.32
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-458.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
4.37%
EPS Q/Q
-115.42%
-
-
-
-
SMA20
-8.7%
SMA50
-32.26%
SMA100
-34.38%
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-8%
ROC
-0.06%
Gross Margin
100%
Oper. Margin
138%
Profit Margin
139%
Payout
-13%
Shs Outstand
350M
Shs Float
334.1M
-
-
-
-
Target Price
-
52W Range
40.6-77.4
52W High
-48.96%
52W Low
-1.75%
RSI
25
Rel Volume
1.06
Avg Volume
817.01K
Volume
868.56K
Perf Week
-6.43%
Perf Month
-18.8%
Perf Quarter
-43.37%
Perf Half Y
-45.72%
-
-
-
-
Beta
0.163
-
-
Volatility
1.56%, 2.31%
Prev Close
-2%
Price
39.3
Change
-4.73%
LABS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0.02 | -0.06 | |
Net income per share | 0.02 | -0.08 | |
Operating cash flow per share | 0.01 | 0 | |
Free cash flow per share | 0.01 | -0.02 | |
Cash per share | 0.47 | 0.03 | |
Book value per share | 1 | 0.91 | |
Tangible book value per share | 1 | 0.91 | |
Share holders equity per share | 1 | 0.91 | |
Interest debt per share | 0 | 0.43 | |
Market cap | 354.38M | 253.05M | |
Enterprise value | 188.41M | 352.28M | |
P/E ratio | 45.78 | -9.16 | |
Price to sales ratio | 43.64 | -12.7 | |
POCF ratio | 100.16 | -232.58 | |
PFCF ratio | 100.16 | -28.99 | |
P/B Ratio | 1.01 | 0.79 | |
PTB ratio | 1.01 | 0.79 | |
EV to sales | 23.2 | -17.68 | |
Enterprise value over EBITDA | 24.34 | -12.83 | |
EV to operating cash flow | 53.25 | -323.78 | |
EV to free cash flow | 53.25 | -40.36 | |
Earnings yield | 0.02 | -0.11 | |
Free cash flow yield | 0.01 | -0.03 | |
Debt to equity | 0 | 0.46 | |
Debt to assets | 0 | 0.33 | |
Net debt to EBITDA | -21.44 | -3.61 | |
Current ratio | 0 | 20.42 | |
Interest coverage | 0 | -7.26 | |
Income quality | 0.46 | 0.04 | |
Dividend Yield | 0 | 0.01 | |
Payout ratio | 0 | -0.13 | |
Sales general and administrative to revenue | 0.05 | -0.38 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 7.02 | |
Capex to revenue | 0 | 0.38 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 0.71 | 1.27 | |
ROIC | 0.02 | -0.06 | |
Return on tangible assets | 0.02 | -0.06 | |
Graham Net | 0.69 | -0.23 | |
Working capital | 166.94M | 19.95M | |
Tangible asset value | 350.58M | 319.45M | |
Net current asset value | 156.12M | -107.4M | |
Invested capital | 0 | 0.46 | |
Average receivables | 0 | 5.67M | |
Average payables | 0 | 513.5K | |
Average inventory | 0 | 111.91M | |
Days sales outstanding | 44.14 | -189.94 | |
Days payables outstanding | 0 | 43.81 | |
Days of inventory on hand | 134.64K | 2.39K | |
Receivables turnover | 8.27 | -1.92 | |
Payables turnover | 0 | 8.33 | |
Inventory turnover | 0 | 0.15 | |
ROE | 0.02 | -0.09 | |
Capex per share | 0 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-09-30 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0.03 | 0.03 | |
Net income per share | 0 | 0 | -0.1 | 0.02 | |
Operating cash flow per share | 0 | 0 | 0.01 | 0.01 | |
Free cash flow per share | 0 | 0 | -0.01 | -0.01 | |
Cash per share | 0 | 0 | 0.03 | 0.06 | |
Book value per share | 0 | 0 | 0.91 | 0.9 | |
Tangible book value per share | 0 | 0 | 0.91 | 0.9 | |
Share holders equity per share | 0 | 0 | 0.91 | 0.9 | |
Interest debt per share | 0 | 0 | 0.43 | 0.3 | |
Market cap | 0 | 0 | 253.05M | 238M | |
Enterprise value | 0 | 38.13M | 352.28M | 318.94M | |
P/E ratio | 0 | 0 | -1.83 | 11.19 | |
Price to sales ratio | 0 | 0 | 26.79 | 24.15 | |
POCF ratio | 0 | 0 | 77.24 | 55.37 | |
PFCF ratio | 0 | 0 | -58.24 | -52.83 | |
P/B Ratio | 0 | 0 | 0.79 | 0.76 | |
PTB ratio | 0 | 0 | 0.79 | 0.76 | |
EV to sales | 0 | 0 | 37.3 | 32.36 | |
Enterprise value over EBITDA | 0 | 0 | 78.09 | 68.94 | |
EV to operating cash flow | 0 | 0 | 107.53 | 74.21 | |
EV to free cash flow | 0 | 0 | -81.08 | -70.8 | |
Earnings yield | 0 | 0 | -0.14 | 0.02 | |
Free cash flow yield | 0 | 0 | -0.02 | -0.02 | |
Debt to equity | 0 | 0.27 | 0.46 | 0.31 | |
Debt to assets | 0 | 0.2 | 0.33 | 0.22 | |
Net debt to EBITDA | 0 | 0 | 22 | 17.5 | |
Current ratio | 0 | 108.28 | 20.42 | 17.76 | |
Interest coverage | 0 | 0 | 1.04 | 0.79 | |
Income quality | 0 | 0 | -0.09 | 0.81 | |
Dividend Yield | 0 | 0 | 0.01 | 0.04 | |
Payout ratio | 0 | 0 | -0.1 | 1.97 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | -2.33 | -2.05 | |
Capex to revenue | 0 | 0 | -0.81 | -0.89 | |
Capex to depreciation | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 1.42 | 0.55 | |
ROIC | 0 | 0 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0 | -0.08 | 0.01 | |
Graham Net | 0 | 0 | -0.23 | -0.25 | |
Working capital | 1 | 67.16M | 19.95M | 23.84M | |
Tangible asset value | 1 | 357.46M | 319.45M | 314.27M | |
Net current asset value | 1 | -57.86M | -107.4M | -98.76M | |
Invested capital | 0 | 0.27 | 0.46 | 0.31 | |
Average receivables | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 98.79 | 53.98 | |
Days payables outstanding | 0 | 0 | 20.86 | 25.94 | |
Days of inventory on hand | 0 | 0 | 1.14K | 495.42 | |
Receivables turnover | 0 | 0 | 0.91 | 1.67 | |
Payables turnover | 0 | 0 | 4.31 | 3.47 | |
Inventory turnover | 0 | 0 | 0.08 | 0.18 | |
ROE | 0 | 0 | -0.11 | 0.02 | |
Capex per share | 0 | 0 | -0.02 | -0.03 |
LABS.L Frequently Asked Questions
What is Life Science Reit PLC stock symbol ?
Life Science Reit PLC is a GB stock and trading under the symbol LABS.L
What is Life Science Reit PLC stock quote today ?
Life Science Reit PLC stock price is $39.3 today.
Is Life Science Reit PLC stock public?
Yes, Life Science Reit PLC is a publicly traded company.